24/7 Patient Assistance: 760-405-8205

Jarrod Holmes, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

  • Bio & Insurance Information
  • Education & Training


    Duke University School of Medicine

    Medical School


    Naval Medical Center


  • Board Certifications

    American Board of Internal Medicine - Hematology

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Naval Medical Center San Diego

    Languages: English/Spanish

    (619) 532-6400

    34800 Bob Wilson Dr

    San Diego, California 92134

    Read More
  • Publications & Memberships

    Dr. Jarrod Holmes has contributed to 3 publications.

    Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02.

    Mittendorf, E.A., Clifton, G.T., Holmes, J.P., Clive, K.S., Patil, R., Benavides, L.C., Gates, J.D., Sears, A.K., Stojadinovic, A., Ponniah, S., Peoples, G.E.; Cancer. 2012 May 15.

    See more >>

    The GP2 peptide: a HER2/neu-based breast cancer vaccine.

    Clive KS, Tyler JA, Clifton GT, Holmes JP, Ponniah S, Peoples GE, Mittendorf EA; J Surg Oncol. 2012-04-01.

    See more >>

    Final report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patients.

    Mittendorf EA, Clifton GT, Holmes JP, Schneble E, van Echo D, Ponniah S, Peoples GE; Ann. Oncol.. 2014-09-01.

    See more >>


    American Society of Clinical Oncology